Chemokines in pathology and medicine

被引:598
作者
Baggiolini, M
机构
[1] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland
[2] Inst Res Biomed, Bellinzona, Switzerland
关键词
D O I
10.1046/j.1365-2796.2001.00867.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
About 50 human chemokines and nearly 20 receptors have been identified and characterized in little more than a decade since the discovery of interleukin 8 (IL-8). the first chemotactic cytokine. Research in this field has dramatically changed our understanding of leucocyte traffic in inflammation and immunity. This paper has been written for scientists and practitioners in the field of medicine. It reviews in concise and intelligible form information that I consider useful for understanding the role of chemokines in human pathophysiology. The main areas covered are: (i) the basics of chemokine structures, mode of action, activities and selectivity, (ii) newer aspects of the broad involvement of chemokines in the regulation of immune defence and the housekeeping of the immune system: (iii) the role of chemokines in pathology as illustrated by animal models and studies of human diseases, and (iv) novel therapeutic approaches for a variety of inflammatory conditions. which are based on modulation of chemokine activity.
引用
收藏
页码:91 / 104
页数:14
相关论文
共 87 条
[1]   Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine [J].
Amara, A ;
Lorthioir, O ;
Valenzuela, A ;
Magerus, A ;
Thelen, M ;
Montes, M ;
Virelizier, JL ;
Delepierre, M ;
Baleux, F ;
Lortat-Jacob, H ;
Arenzana-Seisdedos, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23916-23925
[2]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[3]   Chemokines and leukocyte traffic [J].
Baggiolini, M .
NATURE, 1998, 392 (6676) :565-568
[4]   Blocking chemokine receptors [J].
Baggiolini, M ;
Moser, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1189-1191
[5]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[6]   CRYSTAL-STRUCTURE OF INTERLEUKIN-8 - SYMBIOSIS OF NMR AND CRYSTALLOGRAPHY [J].
BALDWIN, ET ;
WEBER, IT ;
STCHARLES, R ;
XUAN, JC ;
APPELLA, E ;
YAMADA, M ;
MATSUSHIMA, K ;
EDWARDS, BFP ;
CLORE, GM ;
GRONENBORN, AM ;
WLODAWER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :502-506
[7]   CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis [J].
Barcellos, LF ;
Schito, AM ;
Rimmler, JB ;
Vittinghoff, E ;
Shih, A ;
Lincoln, R ;
Callier, S ;
Elkins, MK ;
Goodkin, DE ;
Haines, JL ;
Pericak-Vance, MA ;
Hauser, SL ;
Oksenberg, JR .
IMMUNOGENETICS, 2000, 51 (4-5) :281-288
[8]   SEQUENCE VARIATION OF A NOVEL HEPTAHELICAL LEUKOCYTE RECEPTOR THROUGH ALTERNATIVE TRANSCRIPT FORMATION [J].
BARELLA, L ;
LOETSCHER, M ;
TOBLER, A ;
BAGGIOLINI, M ;
MOSER, B .
BIOCHEMICAL JOURNAL, 1995, 309 :773-779
[9]   A new class of membrane-bound chemokine with a CX(3)C motif [J].
Bazan, JF ;
Bacon, KB ;
Hardiman, G ;
Wang, W ;
Soo, K ;
Rossi, D ;
Greaves, DR ;
Zlotnik, A ;
Schall, TJ .
NATURE, 1997, 385 (6617) :640-644
[10]   The CCR5 deletion mutation fails to protect against multiple sclerosis [J].
Bennetts, BH ;
Teutsch, SM ;
Buhler, MM ;
Heard, RNS ;
Stewart, GJ .
HUMAN IMMUNOLOGY, 1997, 58 (01) :52-59